Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Non-Current Assets came in at $551.0 million in Q1 2026, up 1.81% year-on-year from $541.2 million in Q1 2025, and up 1.41% quarter-over-quarter from $543.4 million in Q4 2025.

Phibro Animal Health (PAHC) Non-Current Assets (2013 - 2026) Analysis & Trends

Phibro Animal Health's Non-Current Assets history runs 14 years deep, the most recent figure standing at $551.0 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 1.81% year-over-year to $551.0 million in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 18.15% increase from a year earlier, with the FY2025 full-year figure at $550.3 million, up 44.36% from the prior year.
  • Non-Current Assets improved to $551.0 million in Q1 2026 per PAHC's latest filing, from $543.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $551.0 million in Q1 2026 and bottomed at $365.5 million in Q2 2022.
  • The 5-year median for Non-Current Assets is $385.7 million (2023), against an average of $438.8 million.
  • Across the five-year window, Non-Current Assets fell 1.16% in 2024 and soared 44.36% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $380.1 million in 2022, then rose by 1.57% to $386.1 million in 2023, then soared by 39.69% to $539.4 million in 2024, then rose by 0.74% to $543.4 million in 2025, then rose by 1.41% to $551.0 million in 2026.
  • Per Business Quant, the three latest PAHC Non-Current Assets figures stand at $551.0 million (Q1 2026), $543.4 million (Q4 2025), and $549.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn 551.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 551.05 Mn
Dec 31, 2025 543.37 Mn
Sep 30, 2025 549.73 Mn
Jun 30, 2025 550.29 Mn
Mar 31, 2025 541.24 Mn
Dec 31, 2024 539.36 Mn
Sep 30, 2024 395.52 Mn
Jun 30, 2024 381.19 Mn
Mar 31, 2024 381.86 Mn
Dec 31, 2023 386.12 Mn
Sep 30, 2023 380.10 Mn
Jun 30, 2023 385.67 Mn
Mar 31, 2023 379.95 Mn
Dec 31, 2022 380.14 Mn
Sep 30, 2022 378.30 Mn
Jun 30, 2022 365.47 Mn
Mar 31, 2022 369.70 Mn
Dec 31, 2021 340.35 Mn
Sep 30, 2021 337.41 Mn
Jun 30, 2021 342.42 Mn